HB 1223 — Louisiana
ECONOMIC DEVELOPMENT: Establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act
Louisiana legislative agenda & upcoming votes Louisiana session calendar
Summary
- HB 1223 is a bill in the Louisiana House, 2026 session, introduced March 31, 2026.
- Sponsored by Jack McFarland.
- Current status: signed into law.
- Most recent action (June 9, 2026): Signed by the Governor. Becomes Act No. 886.
- 3 recorded votes; the most recent, on May 29, 2026, passed 98-0.
-
State Representative, District 13
Republican
Contact your legislator about this bill
Bill text & documents
- HB1223 Act 886 (opens in a new tab)
- HB1223 Enrolled (opens in a new tab)
- HB1223 Reengrossed (opens in a new tab)
- HB1223 Engrossed (opens in a new tab)
- HB1223 Original (opens in a new tab)
- Senate Committee Amendment, #4163, COM, Adopted (opens in a new tab)
- Senate Committee Amendment, #4047, COM, Draft (opens in a new tab)
- House Floor Amendment, #4483, McFarland, Adopted (opens in a new tab)
- House Committee Amendment, #4134, COM, Adopted (opens in a new tab)
- House Committee Amendment, #3965, COM, Draft (opens in a new tab)
- Resume Digest for HB1223 (opens in a new tab)
- Summary of Senate Amendments to HB1223 (opens in a new tab)
- Senate Green Sheet Digest for HB1223 (opens in a new tab)
- Digest of HB1223 Reengrossed (opens in a new tab)
- Digest of HB1223 Engrossed (opens in a new tab)
- Digest of HB1223 Original (opens in a new tab)
- This bill on Open States (opens in a new tab)
Sponsors
Primary: Jack McFarland
History
- Introduced, completed
- Passed House, completed
- Passed Senate, completed
- Sent to Governor, completed
- Signed into law, completed, current stage
- House Read by title. Lies over under the rules.
- House Read by title, under the rules, referred to the Committee on Commerce.
- House Reported with amendments (12-0).
- House Read by title, amended, ordered engrossed, passed to 3rd reading.
- House Scheduled for floor debate on 04/27/2026.
- House Scheduled for floor debate on 05/05/2026.
- House Notice given.
- House Read by title, returned to the calendar.
- House Scheduled for floor debate on 05/07/2026.
- House Notice given.
- House Read by title, returned to the calendar.
- House Called from the calendar.
- House Scheduled for floor debate on 05/11/2026.
- House Notice given.
- House Read by title, returned to the calendar.
- House Called from the calendar.
-
House
Read third time by title, amended, roll called on final passage, yeas 94, nays 0. Finally passed, title adopted, ordered to the Senate.
Milestone
FINAL PASSAGE (#1141): 94 yes 0 no, 11 other Passed, 100% yes
- House Called from the calendar.
- Senate Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
- Senate Read second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.
- Senate Reported with amendments.
- Senate Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
- Senate Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
- House Received from the Senate with amendments.
-
Senate
Rules suspended. The amended bill was read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
Milestone
FINAL PASSAGE (#1354): 38 yes 0 no, 1 other Passed, 100% yes
- House Scheduled for concurrence on 05/29/2026.
-
House
Read by title, roll called, yeas 98, nays 0, Senate amendments concurred in.
CONCUR IN SENATE AMENDMENTS (#1713): 98 yes 0 no, 7 other Passed, 100% yes
- House Enrolled and signed by the Speaker of the House.
- Senate Signed by the President of the Senate.
- House Sent to the Governor for executive approval.
- House Effective date: 06/09/2026.
- House Signed by the Governor. Becomes Act No. 886. Milestone Latest